Maassarani 2018.

Study name	Pulsed short wave therapy in Cesarean section
Methods	Randomised controlled trial; masking: quadruple (participant, care provider, investigator, outcomes assessor)
Participants	Inclusion criteria Voluntarily Performed using spinal anaesthesia ASA I (normal healthy women) and II (women with mild systemic disease) (as defined by the American Society of Anesthesiologists Physical Status Classification system) First, second, or third CS At term pregnancy (> 38 weeks) BMI <35 Age between 18 to 50 years Exclusion criteria Longitudinal surgical incision Placental abnormalities noted Time of extraction of the fetus > 10 minutes from cutaneous incision Blood loss during surgery of > 800 mL Any of the conditions not considered in inclusion criteria Target sample size: 250 women
Interventions	Intervention: standard protocol for the control of postoperative pain as well as an active RecoveryRx Pulsed Short Wave Therapy device. Control: standard protocol for the control of postoperative pain as well as a sham RecoveryRx Pulsed Short Wave Therapy device.
Outcomes	Change in pain VAS Time to patient mobility Wound closure at day 7 Wound complications
Starting date	01 April 2018
Contact information	Mahmoud Maassarani PhD New Mazloum Hospital, Tripoli, Lebanon +96179156547 | m.maassarani@outlook.fr
Notes	NCT03604068 | No data provided